Navigation Links
Aquavit Pharmaceuticals Inc. Appoints David Shafer, MD., FACS., New Chief Medical Technology Officer
Date:3/4/2013

NEW YORK, March 4, 2013 /PRNewswire/ -- Aquavit Pharmaceuticals Inc. has announced its newest addition to its management team, Dr. David Shafer . He has been appointed Chief Medical Technology Officer and will be leading Aquavit's R&D Medical Technology for Aquavit's product pipeline. 

Prior to joining Aquavit, Dr. Shafer launched the world's first Vectra XT 3D Imaging System, allowing patients to view a 3D simulated breast augmentation, liposuction, mommy makeover, facelift, rhinoplasty, and virtually any procedure on their own body prior to their surgery.

Dr. Shafer's passion for innovation, technology, & improving the overall patient experience, has led him to create the world's first-ever plastic surgery themed iPhone application. The App features over 1000 interactive FAQs about plastic surgery – from invasive surgeries to non-invasive procedures. Dr. Shafer has described today's plastic surgery patient as "sophisticated, inquisitive and information seeking", and created this resource with them in mind. With an eye for achieving natural looking results, Dr. Shafer has repeatedly been voted TOP DOC for Botox, Liposuction, Tummy Tuck, and Facelift among many other categories. W Magazine also picked up on the buzz, and featured Dr. Shafer as a "Beauty Talent soon to be on your speed-dial." 

"We are thrilled to have Dr. Shafer leading our medical technology pipeline development," said Sobin Chang , Aquavit's Chief Executive Officer. "Dr. Shafer will provide us with valuable input for all of our Commercial Planning and Operational needs, in addition to building KOL advocacy with Dr. Steven Fagien , our Chief Medical Officer."

Dr. Shafer is a NYC double board certified plastic surgeon, a Diplomat of the American Board of Plastic Surgery & a Member of the American Society of Plastic Surgeons. He is trained in all aspects of plastic and reconstructive surgery, but specializes in aesthetic surgery. He was trained at the world renowned Mayo Clinic, which is consistently ranked as the best in class for hospitals and surgical training. Additionally, he completed a prestigious fellowship at MEETH, making him an expert in Aesthetic Surgery.

About Aquavit

Aquavit Pharmaceuticals is a high-tech pharmaceutical company founded in New York City in 2010.  We provide comprehensive range of innovative pharmaceutical, biotech and medical device technologies, developing first of its kind, smart desktop compounding technology with AI integration and big data vertical.

Aquavit is pioneering personalized medicine using advanced technology to improve patients' health, maximize the efficiency of our medical community, and support the pharmacoeconomics of our payers.

This strategic focus is aligned with our modernized and diversified approaches. It is this combination that enables our research and development to address unmet needs.

Aquavit Pharmaceuticals aim to serve both clinicians and patients with the latest innovations in end-to-end personalized healthcare.


'/>"/>
SOURCE Aquavit Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Aquavit Pharmaceuticals forms Alliance Partnership with Accelrys
2. Aquavit and Green Cross Sign Strategic Collaboration MOU on IBX-001 Product Development and Commercialization in Asia
3. TauRx Pharmaceuticals Receives $10.5m Follow-On Investment from Dundee Corporation
4. Jazz Pharmaceuticals Announces Public Offering Of Ordinary Shares By Selling Shareholders
5. Imprimis Pharmaceuticals Out Licenses Its Proprietary IP to resolutionMD for Cosmeceutical Products
6. Auxilium Pharmaceuticals, Inc. to Present at the Cowen and Company 33rd Annual Healthcare Conference
7. Arena Pharmaceuticals Provides Corporate Update and Reviews Fourth Quarter and Full Year 2012 Financial Results
8. AVANIR Pharmaceuticals To paticipate in two conferences in March
9. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Fourth Quarter And Full Year 2012 Financial Results On March 7, 2013
10. Adamis Pharmaceuticals Prevails in License Dispute Litigation
11. Cumberland Pharmaceuticals Reports 2012 Annual Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)...  Eli Lilly and Company (NYSE: LLY ... quarter of 2017 on Tuesday, October 24, 2017. Lilly ... with the investment community and media to further detail ... will begin at 9 a.m. Eastern time. Investors, media ... of the conference call through a link that will ...
(Date:9/28/2017)... 2017 Cohen Veterans Bioscience and Early Signal ... wearable and home sensors for real-time monitoring of patients ... a nonprofit organization focused on disruptive health solutions for ... analytical system to record and integrate behavioral, cognitive, physiological ... ...
(Date:9/23/2017)... -- Janssen Biotech, Inc. (Janssen) announced today that it ... Food and Drug Administration (FDA) for the Biologics License ... of moderately to severely active rheumatoid arthritis (RA). The ... to further evaluate the safety of sirukumab in the ... "We are disappointed by ...
Breaking Medicine Technology:
(Date:10/13/2017)... Fairfax, VA (PRWEB) , ... October 13, 2017 ... ... provider of DevOps and Agile Software Development, has been awarded a contract by ... (EATS) Blanket Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and the loss ... author, William Nowers. Captain Nowers and his wife, Millie, have six children, ten ... the Navy. Following his career as a naval aviator and carrier pilot, he ...
(Date:10/12/2017)... ... 12, 2017 , ... CitiDent and San Francisco dentists, Dr. ... Oventus O2Vent technology. As many as 18 million Americans are estimated to suffer ... Oral appliances can offer significant relief to about 75 percent of people with ...
(Date:10/12/2017)... WAUSAU, Wis. (PRWEB) , ... October 12, 2017 ... ... formulated standard products to meet the demand of today’s consumer and regulatory authorities ... team of probiotic experts and tested to meet the highest standard. , ...
(Date:10/12/2017)... Bethesda, MD (PRWEB) , ... October 12, 2017 , ... ... Award of Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s ... 4 – 8. , In honor of Morris F. Collen, a pioneer in the ...
Breaking Medicine News(10 mins):